Grifols | GRFS - Deudores Comerciales

Precio De Mercado
7.65
Cambio Diario
0.07 0.92%
Mensual
-15.66%
Anual
-1.80%
Q1 Expectativa
7.36




Deudores Comerciales Cambio Fecha
Alaunos Therapeutics USD 2K 0 2025-06
aTyr Pharma USD 296.74M 295.7M 2025-12
Brainstorm Cell Therapeutics USD 80K 26K 2025-09
Capricor Therapeutics USD 59K 0 2025-12
Cara Therapeutics USD 2.24M 2.26M 2025-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Grifols EUR 1B 285.88M 2025-12
Immunic USD 1.5M 50K 2024-06
Nektar Therapeutics USD 0 2.9M 2024-09
Sangamo BioSciences USD 581K 110K 2024-06
TherapeuticsMD USD 2.91M 310K 2024-06